Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
Current standards of treatment in ms and the role of oral agents.
T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2.
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical features.
Computer-based diagnosis of illness in historical persons.
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
Acute Disseminated Encephalomyelitis: The Time Until Diagnosis and Its Subsequent Course in Children.
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Multicenter measurements of myelin water fraction and geometric mean T2 : Intra- and intersite reproducibility.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients.
CD4+ T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Fingolimod Reduces Direct Medical Costs Compared to Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis in the Netherlands.
Silent aspiration and recovery from Dysphagia in a case of bickerstaff brainstem encephalitis.
Detection of B-cell populations with monotypic light chain expression in cerebrospinal fluid specimens from patients with multiple sclerosis by polychromatic flow cytometry.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
[Diet and multiple sclerosis].
Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.
Chemokines and chemokine receptors in multiple sclerosis.
Pages
« first
‹ previous
…
342
343
344
345
346
347
348
349
350
…
next ›
last »